Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Randomised, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of MEDI3506 in Adult Participants With Uncontrolled Moderate-to-severe Asthma

NCT04570657 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT04570657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04570657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Randomised, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of MEDI3506 in Adult Participants With Uncontrolled Moderate-to-severe Asthma
Lead sponsor
AstraZeneca
Phase
Phase 2
Overall status
Completed
Start date
September 17, 2020
Completion date
February 6, 2023
Enrollment
250 (actual)
Sites
65

Conditions

As the registry lists them; a condition with its own page is linked.

asthma